European Pharmacovigilance Congress 2024

18-19 Novembre 2024
Online
English
 
22 Novembre 2024
Face-to-Face in Milan
English
 

Panoramica della conferenza

The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences.
EUPV congress is proud to have high quality scientific content as its main characteristic which has attracted growing interest from speakers, sponsors and participants from all over the world.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors,) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
To further improve the value of the congress and continuously make it more and more interesting by bringing new ideas and scientific contents, this year the  Scientific Advisory Group has been further widened with the addition of new PV key opinion leaders who need no introduction since their knowledge and skills are world class.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.

Format del congresso

The European Pharmacovigilance Congress will be a mixed event!

18-19 November | Virtual 9 am- 6 pm
21 November | APERITIF TIME, NH Milano Congress Centre 6 pm – 9 pm
22 November | Face to face, NH Milano Congress Center 9.30 am – 5 pm

APERITIF TIME – November 21 from 6 to 9 pm – NH Milano Congress
Reserve your place to meet and network with your colleagues, experts and opinion leaders!

This year the congress will include:
25 Topics
11 Virtual & Face-to-Face Parallel Sessions
25 Interactives Round Tables
2 Face to-Face Workshops
2 LECTIO Magistralis

Perchè partecipare?

  • Learn about the latest Pharmacovigilance trends and updates
  • Share experiences and solutions at a leading European event
  • Forge new collaborations with key decision makers
  • Networking through the virtual platform with Pharma Companies Delegates and Speakers

A chi è rivolto?

  • Pharma, Biotech and Medical Devices Industries
  • Pharmacovigilance Associations
  • Regulatory Bodies
  • CROs and CMOs
  • Clinical Research Sites
  • Data Management Companies
  • Software Development Companies
  • University Faculties
  • PV Consultant Societies

TOPICS 2024 - In Progress...

THEMATIC SESSIONS

18/11 – Virtual
– Biological Basis of Adverse Reactions (with focus on SCARs)
– Immunological Adverse Reactions
– Signal Detection
– Risk Management
– LECTIO Magistralis

19/11  – Virtual
– Authorities’ Assessment of PV Reports
– Real Word Data & Real Word Evidence
– Manufacturing & PV Interfaces
-Drug Safety in Marketing Authorization Applications
-LECTIO Magistralis

22/11 – Milan
– Evolving Pharmacovigilance Strategies
– Main Global and Local PV Updates
– Practical Experience of Applying Artificial Intelligence in PV
– Audit & Inspections

and more parallel sessions coming …

November 18th 2024, Virtual - In Progress...


SESSION 1 - Biological Basis of Adverse Reactions (with focus on SCARs)

Arduino Mangoni, Strategic Professor in Clinical
Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia

Chia-Yu Chu | Prof. Department of Dermatology | National Taiwan University

Georgios Papazisis | Professor of Clinical Pharmacology; Medical Director, Clinical Research Unit, School of Medicine | Aristotle University of Thessaloniki, Greece

SESSION 2 - Immunological Adverse Reactions

Mattia Calissano | Head of Pharmacovigilance | Orchard Therapeutics

Anne de Groot | CEO/CSO and Director | EpiVax

Amy Rosenberg | Senior Director and Consultant,
Immunology | EpiVax, Inc

SESSION 3 - Signal Detection

Natsiavas Pantelis | Researcher (Grade C) | Institute of Applied Biosciences of Centre for Research and Technology Hellas (INAB|CERTH), Thessaloniki, Greece

Gianluca Trifirò | Full Professor of Pharmacology
-Department of Diagnostics and Public Health | University of Verona

Vibha Jawa | Executive Director for Biotherapeutics
Bioanalysis in clinical Pharmacology, Pharmacometrics
and Bioanalysis (NDB) organization | Bristol Myers
Squibb

SESSION 4 - Risk Management

Robert Massouh | Head of (PV) Risk Management and Benefit Risk Evaluation | Gsk

Klaudija Marijanovic Barac | Sr. Director, EU&UK QPPV Deputy, Head Periodic Reports and Risk Management Unit | TEVA

Giovanna Paolone | Associate Professor of Pharmacology – Department of Diagnostics and Public Health | University of Verona

SESSION 5 - LECTIO Magistralis

Nicholas Moore | Emeritus Professor of Clinical Pharmacology | University of Bordeaux

November 19th 2024, Virtual - In Progress...


SESSION 6 - Authorities' Assessment of PV Reports

John Joseph Borg | Director Post-Licensing | Malta
Medicines Authority

Roxana Dondera | Head of Pharmacovigilance and Risk Management Unit | National Agency for Medicine and Medical Devices of Romania

Sophia Trantza | Senior Pharmacovigilance Expert | PRAC member Greece

SESSION 7 - Real Word Data & Real Word Evidence

Lembit Rago | Secretary-General |Council for International Organizations of Medical Sciences (CIOMS)

Željana Margan Koletić | Senior Manager, Risk
Management Plans (RMP) Team Leader | Teva

Fatema Alqenae | Pharmacist | Kuwait – Winner EUPV 2023 Award

SESSION 8 - Manufacturing & PV Interfaces

AIFA Representative (tbc)

Terenzio Ignoni | SVP Quality and CMC | Gain Therapeutics

Dina B. Tresnan | Disease Area Cluster Lead – Immunolo-Oncology; Safety Surveillance and Risk Management, Worldwide Safety | Pfizer

Valentina Mancini | Senior Director Pharmacovigilance QPPV | Shionogi Europe

SESSION 9 - Drug Safety in Marketing Authorization Applications

Maria Beatrice Panico | Principal Consultant | Scendea

SESSION 10- LECTIO Magistralis

Glyn Belcher | Senior Scientific Advisor | EU PV
Congress

November 22nd, Face-to-Face - In Progress...


SESSION 11 - Evolving Pharmacovigilance Strategies

Giovanni Furlan | Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.

Andrew Bate | VP Safety Innovation & Analytics | GSK

Marcin Kruk | Drug Safety Regional Head Europe ,
Africa, Middle East, Worlwide Medical & Safety | Pfizer Inc.

Sophia Trantza | Senior Pharmacovigilance Expert |
PRAC Member Greece

SESSION 12 - Main Global and Local PV Updates

Calin Lungu | DDCS S.A., CEO

Ilaria Grisoni | Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals

Marcela Fialova | Chief Operating Officer | iVigee

SESSION 13 - Practical Experience of Applying Artificial Intelligence in PV

Andrew Bate | VP Safety Innovation & Analytics | GSK

Phil Tregunno | Deputy Director, Patient Safety
Monitoring, Safety and Surveillance | MHRA

Gabriel Westman | Head of Artificial Intelligence |
Swedish Medical Products Agency

Maurizio Sessa | Associate Professor of Pharmacoepidemiology | University of Copenhagen

SESSION 14 - Audit & Inspections

AIFA Representative (tbc)

Gian Nicola Castiglione | Pharmacovigilance Senior
Consultant, Member and Secretary of SIMeF, ETS
Board, Master of Labor. Past Head of Global Pharmacovigilance and EU-UK QPPV | Chiesi Farmaceutici S.p.A.

Iva Novak | Head of European Pharmacovigilance and
EU QPPV | Teva

Scientific Advisory Group 2024 - In Progress...


Andrew Bate

Andrew Bate

VP, Head of Safety Innovation & Analytics | GSK

Glyn Belcher

Glyn Belcher

Senior Scientific Advisor | EU PV
Congress

Mattia Calissano

Mattia Calissano

Head of Pharmacovigilance | Orchard Therapeutics

Gian Nicola Castiglione

Gian Nicola Castiglione

Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Past Head of Global Pharmacovigilance and EU-UK QPPV | Chiesi Farmaceutici S.p.A.

Mircea Ciuca

Mircea Ciuca

Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance

Giovanni Furlan

Giovanni Furlan

Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.

Calin Lungu

Calin Lungu

DDCS S.A., CEO

Hrvoje Maček

Hrvoje Maček

VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance

Valentina Mancini

Valentina Mancini

Senior Director Pharmacovigilance, QPPV | Shionogi Europe

Jan Petracek

Jan Petracek

CEO | iVigee
Director, Institute of Pharmacovigilance

Marco Sardella

Marco Sardella

Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech

Speakers 2024 - In Progress...


John -Joseph Borg

John -Joseph Borg

Director Post-Licensing | Malta Medicines Authority

Fazil Afzal

Fazil Afzal

Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)

Klaudija Marijanovic Barac

Klaudija Marijanovic Barac

Sr. Director, EU&UK QPPV Deputy, Head Periodic Reports and Risk Management Centre | TEVA

Andrew Bate

Andrew Bate

VP Safety Innovation & Analytics | GSK

Glyn Belcher

Glyn Belcher

Senior Scientific Advisor | EU PV Congress

Mayssa AbouGhannam

Mayssa AbouGhannam

Country Safety Team Lead, Saudi Arabia, Gulf, Pakistan, Afghanistan | Johnson & Johnson

Margherita D'Antuono

Margherita D'Antuono

EU-UK QPPV| Piramal Critical Care

Anne De Groot

Anne De Groot

CEO/CSO and Director | Epivax

Roxana Dondera

Roxana Dondera

Head of Pharmacovigilance and Risk Management Unit | National Agency for Medicine and Medical Devices of Romania

Ilaria Grisoni

Ilaria Grisoni

Executive Director, Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals

Terenzio Ignoni

Terenzio Ignoni

SVP Quality and CMC | Gain Therapeutics

Vibha Jawa

Vibha Jawa

Executive Director | Bristol Myers Squibb

Calin Lungu

Calin Lungu

DDCS S.A., CEO

Arduino Mangoni

Arduino Mangoni

Strategic Professor in Clinical Pharmacology | Flinders University; Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia

Zeljana Margan Koletic

Zeljana Margan Koletic

Senior Manager, Risk Management Plans (RMP) Team Leader | Teva

Robert Massouh

Robert Massouh

Head of (PV) Risk Management and Benefit Risk Evaluation | Gsk

Nicholas Moore

Nicholas Moore

Emeritus Professor of Clinical Pharmacology | University of Bordeaux

Georgios	Papazisis

Georgios Papazisis

Professor of Clinical Pharmacology; Medical Director, Clinical Research Unit | School of Medicine, Aristotle University of Thessaloniki

Lembit Rägo

Lembit Rägo

Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)

Sofia Trantza

Sofia Trantza

Senior Pharmacovigilance Expert , PRAC member Greece

Maria Beatrice Panico

Maria Beatrice Panico

Principal Consultant | Scendea

Amy	Rosemberg

Amy Rosemberg

Senior Director and Consultant, Immunology | EpiVax, Inc

Geeta Shanbhag

Geeta Shanbhag

VP Pharmacovigilance and Medico-Regulatory Affairs | Ipca Laboratories Ltd

Alqenae Fatema

Alqenae Fatema

Pharmacist | University of Manchester –
Winner EUPV 2024 Award

Iva Novak

Iva Novak

Head of European Pharmacovigilance and EU QPPV | Teva

Chia Yu Chu

Chia Yu Chu

Prof. Department of Dermatology | National Taiwan University

Marcin Kruk

Marcin Kruk

Drug Safety Regional Head Europe , Africa, Middle East, Worlwide Medical & Safety |Pfizer Inc.

Phil Tregunno

Phil Tregunno

Deputy Director, Patient Safety Monitoring, Safety and Surveillance | MHR

Maurizio Sessa

Maurizio Sessa

Associate Professor of Pharmacoepidemiology | University of Copenhagen

Gabriel Westman

Gabriel Westman

Head of Artificial Intelligence | Swedish Medical Products Agency

Giovanna Paolone

Giovanna Paolone

Associate Professor of Pharmacology – Department of Diagnostics and Public Health | University of Verona

Dina B. Tresnan

Dina B. Tresnan

Disease Area Cluster Lead -Immunolo-Oncology; Safety
Surveillance and Risk Management, Worldwide Safety | Pfizer

Marcela Fialova

Marcela Fialova

Chief Operating Officer | iVigee

Iva Galic

Iva Galic

Pharmacovigilance Inspector Expert | HALMED

Sponsors & Media Partners 2024 - In Progress...

iVigee

Sponsor
iVigee

Pharma D&S

Sponsor
Pharma D&S

ProductLife Group

Sponsor
ProductLife Group

Diventa sponsor

The European Pharmacovigilance Congress provides an excellent opportunity to get in touch with PV professionals and decision makers through a powerful virtual exhibition area. To sponsor the event, contact us.

Sede del congresso

The European Pharmacovigilance Congress 2024 will be a mixed event:

Step 1

On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:

  • Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
  • Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
  • Join Q&A times and round tables to discuss the current hot topics in the field
  • Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance

Step 2

Let’s finally meet face to face in Milan on November 22! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.

Edizioni precedenti

Scarica le brochure delle precedenti edizioni di European Pharmacovigilance Congress 2024

Iscriviti alla conferenza

Face-to-Face (22/11/24)
Early bird fino al 18/10/2024*

400€
500€

Virtual (18-19/11/24)
Early bird fino al 18/10/2024*

600€
650€

Virtual + Face to Face (18-19/11/24 e 22/11/24)
Early bird fino al 18/10/2024*

750€
950€

* Ospedali, università e liberi professionisti ottengono uno sconto del 40% da applicare ai prezzi pubblicati (gli sconti non sono cumulabili).

Richiedi informazioni